Search Results

Displaying Results 1-1 of 1 "'EXPD'"
Making a selection with these dropdown will cause content on this page to change. News search result will update as each option is selected.
NYSE Content Update: Expedition Therapeutics Secures $115 Million Series B

Aug 05, 2026, 08:55 ET NYSE Content Update: Expedition Therapeutics Secures $115 Million Series B

following her firm's latest funding round.The company says the first patients have been dosed in its Phase 2 clinical trial for EXPD-101, a next-gen treatment for COPD.Zeta Global (NYSE: ZETA) CEO David Steinberg will join NYSE Live to deliver the biggest takeaways

More news about: New York Stock Exchange

Making a selection with these dropdown will cause content on this page to change. News search result will update as each option is selected.